DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Efficacy Methadone for Management Postoperative Pain After the Use of Anesthesia Intravenous in Laparoscopic Cholecystectomy

Information source: Universidad de Valparaiso
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Pain, Postoperative

Intervention: Morphine (Drug); Methadone (Drug); TIVA (Drug)

Phase: N/A

Status: Recruiting

Sponsored by: Universidad de Valparaiso

Official(s) and/or principal investigator(s):
Nicolas M ARRIAZA, Physician, Principal Investigator, Affiliation: University Valparaiso


The aim of this study is to compare the efficacy of methadone versus morphine in dealing with postoperative pain, in laparoscopic cholecystectomy under total intravenous anesthesia (TIVA); Efficacy is defined in terms of the difference of milligrams in morphine used as rescue analgesia postoperatively. Our hypothesis is that methadone is more effective than morphine for postoperative pain treatment.

Clinical Details

Official title: Efficacy Methadone for Management Postoperative Pain After the Use of Anesthesia Intravenous in Laparoscopic Cholecystectomy

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment

Primary outcome: Difference in milligrams of morphine used as rescue analgesia

Secondary outcome: Difference in pain scores, using the Numeric Rating Scale

Detailed description: Patients undergo laparoscopic cholecystectomy at Almirante Nef Naval Hospital will be recruited, between March and July 2013. The sample size was calculated to obtain an average difference of 4 mg of morphine (DE 1. 5) to 3 mg of morphine (DE 1. 5), with a power of 80% and a significance level of 0. 05. This came down to 36 randomized patients into each group, so 86 patients will be recruited considering a 15% loss to follow up. Before signing an informed consent, we will explain to them how to classify pain intensity numerical rating scale (NRS) and this will be evaluated periodically during the first 24 hours after surgery. General anesthesia will be based on Remifentanil and Propofol, titrated to achieve bispectral index (BIS) between 40 and 60. Patients will be randomized into methadone group (ME) and morphine group (MO), they will receive 0. 08 mg / kg bolus of methadone or 0. 08 mg / kg bolus of morphine as applicable at the time of beginning surgery. Postoperative analgesia will be standard for both groups. Patient´s demographic data will be filed as well as surgical timings. All patients will remain in the anesthetic recovery room for the first two hours , to get a record taken of vital signs and measurement of NRS at 5, 15, 30, 60 and 120 minutes. If NRS is greater than or equal to 4, 1 mg of morphine ev will be used as analgesic rescue. In room measuring NRS continue hospitalized at 4, 8, 12 and 24 hours postoperatively and were used as rescue analgesia if ketorolac 30mg ev NRS is greater than or equal to 4. The amount of morphine is registered and ketorolac rescue of both groups as well as pain assessment scores. The occurrence of adverse effects such as nausea, vomiting, pruritus, urinary retention and respiratory depression is also recorded in both groups, to be compared later as a secondary objective.


Minimum age: 18 Years. Maximum age: 70 Years. Gender(s): Both.


Inclusion Criteria:

- Patients undergoing laparoscopic cholecystectomy in the Almirante Nef Naval Hospital

- Patients ASA 1 or 2

Exclusion Criteria:

- Patients with renal insufficiency (creatinine> 2. 0 mg / dl)

- Patients with a history of liver failure

- Patients with BMI> 35 kg/m2

- Patients with hypersensitivity to the drugs in question

- History of chronic use of opioids

- Need for conversion to open surgery

Locations and Contacts

Almirante Nef Naval Hospital, Viña del Mar, Valparaiso, Chile; Recruiting
Nicolas M Arriaza, Physician, Phone: 5697106963, Email: narriaza@gmail.com
Nicolas M Arriaza, Physician, Principal Investigator
Additional Information

Starting date: March 2013
Last updated: April 16, 2013

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017